MedTrace Logo

Serum Metabolomics Study of Polycystic Ovary Syndrome

NCT03618342 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1272

Last updated 2020-03-23

No results posted yet for this study

Summary

Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder, which produces in 5-20% reproductive age women. In this study, a nontargeted metabolomics approach based on ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry will be used to investigate serum metabolic characteristics of PCOS. PCOS women and healthy control will be divided into two distinct groups based on multivariate statistical analysis. The findings of this study will offer a new insight to understand the pathogenesis mechanism, and the discriminating metabolites may provide a prospect for PCOS diagnosis.

Conditions

  • Polycystic Ovary Syndrome

Sponsors & Collaborators

  • Heilongjiang University of Chinese Medicine

    lead OTHER

Eligibility

Min Age
14 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-02
Primary Completion
2019-08-31
Completion
2020-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618342 on ClinicalTrials.gov